Poland· PL-100016127

CromoHexal

A cromoglicic acid product containing natrii cromoglicas, registered in Poland by Sandoz GmbH. The same ATC class is registered in 5 of our 19 countries.

ATC R01AC01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCromoHexalATCR01AC01REGISTER NO.PL-100016127PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Cromoglicic acid is registered in 5 of 19 countries.

Countries holding a registration under ATC R01AC01 (cromoglicic acid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Cromoglicic acid · ATC R01AC01

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Natrii cromoglicas
Manufacturer
Sandoz GmbH
Country
Poland (PL)
ATC code
R01AC01
ATC class
Cromoglicic acid
Defined daily dose
40 mg, N
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990346417

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cromoglicic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cromoglicic acid products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Allergo-Comod, Allergocrom
  • Belgium · Allergo-Comod, Cromabak
  • Bulgaria · Lecrolyn Sine
  • Cyprus · Cromodal, Vividrin
  • Czechia · Allergo-Comod, Allergocrom
  • Germany · Allergoval, Cromo
  • Denmark · Lecrolyn Sine, Lomudal
  • Estonia · Lecrolyn, Lecrolyn Sine
  • Spain · Gastrofrenal
  • Finland · Lecrolyn, Lecrolyn Sine
  • France · Alairgix Rhinite Allergique, Allergocomod
  • United Kingdom (Northern Ireland) · Alleopti Allergy, Alleopti Hayfever
  • Greece · Allergotin, Chromoprol
  • Hungary · Lecrolyn, Taleum
  • Ireland · Opticrom, Opticrom Allergy
  • Iceland · Lecrolyn Sine, Lomudal
  • Italy · Brunicrom, Lecrosine
  • Lithuania · Lecrolyn, Lecrolyn Sine
  • Luxembourg · Allergo-Comod, Cromabak
  • Latvia · Lecrolyn Sine
  • Malta · Allergo-Comod, Allergotin
  • Netherlands · Allerg-Abak, Allergieneusspray Natriumcromoglicaat Etos
  • Norway · Lecrolyn Sine, Lomudal
  • Portugal · Allergocrom, Cromabak
  • Romania · Alergorom, Lecrolyn
  • Sweden · Allgil, Lecrolyn
  • Slovakia · Allergocrom, Lecrolyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/78d8151d-79e1-405a-9cd5-6299a487e506
GET /v1/drugs/78d8151d-79e1-405a-9cd5-6299a487e506?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol do nosa, roztwór",
  "source": "urpl",
  "strength": "2,8 mg/dawkę donosową",
  "packaging": "Rp ¦ Skasowane ¦ 2740\n1 poj. 15 ml\n05909990346417 ¦ OTC ¦ 43252\n2 poj. 15 ml",
  "substance": "Natrii cromoglicas 2.8 mg",
  "common_name": "Natrii cromoglicas",
  "pl_product_id": "100016127",
  "pozwolenie_nr": "03464",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-03-01"
}

See everything about cromoglicic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.